Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease
Open Access
- 1 September 2001
- Vol. 56 (9) , 713-720
- https://doi.org/10.1136/thorax.56.9.713
Abstract
BACKGROUND Bronchodilator reversibility testing is recommended in all patients with chronic obstructive pulmonary disease (COPD) but does not predict improvements in breathlessness or exercise performance. Two alternative ways of assessing lung mechanics—measurement of end expiratory lung volume (EELV) using the inspiratory capacity manoeuvre and application of negative expiratory pressure (NEP) during tidal breathing to detect tidal airflow limitation—do relate to the degree of breathlessness in COPD. Their usefulness as end points in bronchodilator reversibility testing has not been examined. METHODS We studied 20 patients with clinically stable COPD (mean age 69.9 (1.5) years, 15 men, forced expiratory volume in one second (FEV1) 29.5 (1.6)% predicted) with tidal flow limitation as assessed by their maximum flow-volume loop. Spirometric parameters, slow vital capacity (SVC), inspiratory capacity (IC), and NEP were measured seated, before and after nebulised saline, and at intervals after 5 mg nebulised salbutamol and 500 μg nebulised ipratropium bromide. The patients attended twice and the treatment order was randomised. RESULTS Mean FEV1, FVC, SVC, and IC were unchanged after saline but the degree of tidal flow limitation varied. FEV1 improved significantly after salbutamol and ipratropium (0.11 (0.02) l and 0.09 (0.02) l, respectively) as did the other lung volumes with further significant increases after the combination. Tidal volume and mean expiratory flow increased significantly after all bronchodilators but breathlessness fell significantly only after the combination treatment. The initial NEP score was unrelated to subsequent changes in lung volume. CONCLUSIONS NEP is not an appropriate measurement of acute bronchodilator responsiveness. Changes in IC were significantly larger than those in FEV1and may be more easily detected. However, our data showed no evidence for separation of “reversible” and “irreversible” groups whatever outcome measure was adopted.Keywords
This publication has 26 references indexed in Scilit:
- Expiratory Flow Limitation in Stable Asthmatic Patients During Resting BreathingAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Reliability of Inspiratory Capacity for Estimating End-expiratory Lung Volume Changes during Exercise in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.American Journal of Respiratory and Critical Care Medicine, 1996
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Critical evaluation of computerised x ray planimetry for the measurement of lung volumes.Thorax, 1995
- A simple method to detect expiratory flow limitation during spontaneous breathingEuropean Respiratory Journal, 1995
- Breathlessness in Patients with Severe Chronic Airflow LimitationChest, 1992
- Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapyRespiratory Medicine, 1991
- Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.Thorax, 1987
- Role of the Parasympathetic System in Airway Obstruction Due to EmphysemaNew England Journal of Medicine, 1984